Fig. 1From: Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational studyStudy design: a prospective observational study. IDegAsp insulin degludec/insulin aspart, QOL quality of lifeBack to article page